Term ends Mar 12, 2028 · Medium confidence
20-year base term ends Mar 12, 2028
Why Medium: A parent in the chain could not be resolved.
Mar 12, 2008
Mar 12, 2028
May 14, 2013
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 12, 2008, when application PCT/US2008/003353, the earliest non-provisional in its chain, was filed (this one was filed Mar 21, 2012); a parent in its chain could not be resolved (the next row) | Mar 12, 2028 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,173,666) | resolves to Mar 12, 2028, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 12, 2028 | Medium confidence |
This family
| Application PCT/US2008/003353 | PCT application no patent term | no patent term |
| US 8,173,666 | In force May 2029 | May 2029 |
| Application PCT/US2009/005174 | PCT application no patent term | no patent term |
| Application PCT/US2010/042792 | PCT application no patent term | no patent term |
| Application 13/063,919 | Abandoned not computed | not computed |
| US 8,440,687 | this patent Mar 2028 | Mar 2028 |
| US 8,575,196 | In force Mar 2028 | Mar 2028 |
| US 8,569,343 | In force Mar 2028 | Mar 2028 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 17, 2012 Reel 28571, frame 141 | Nektar Therapeutics | Wells Fargo Bank, National Association, as Collateral Agent | Grant of Security Interest |
| Dec 17, 2012 Reel 29480, frame 519 | Riggs-sauthier, Jennifer; Deng, Bo-liang; Riley, Timothy A. | Nektar Therapeutics | Assignment of Assignor's Interest |
| Oct 6, 2015 Reel 36796, frame 562 | Nektar Therapeutics | TC Lending, LLC, as Collateral Agent | Grant of Security Interest in United States Patents |
| Oct 14, 2015 Reel 36866, frame 700 | Wells Fargo Bank, National Association, as Collateral Agent | Nektar Therapeutics | Release of Security Interest Recorded at Reel 28571, Frame 0141 |
| Oct 28, 2019 Reel 50846, frame 940 | Inheris Pharmaceuticals, Inc. | TC Lending, LLC, as Collateral Agent | Security Interest |
| Oct 28, 2019 Reel 50846, frame 461 | Nektar Therapeutics | Inheris Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Nov 15, 2019 Reel 51038, frame 585 | Inheris Pharmaceuticals, Inc. | Inheris Biopharma, Inc. | Change of Name |
| Apr 17, 2020 Reel 52435, frame 62 | TC Lending, LLC, as Collateral Agent | Inheris Biopharma, Inc. | Release of Security Interest |
| Apr 17, 2020 Reel 53180, frame 9 | TC Lending, LLC, as Collateral Agent | Nektar Therapeutics | Release of Security Interest |
| Jan 9, 2023 Reel 62313, frame 501 | Inheris Biopharma, Inc. | Nektar Therapeutics | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,173,666, ends no earlier than this term, so it caps nothing.